{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:49:26Z","timestamp":1781509766568,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Jeanssons foundation"},{"name":"Gothenburg Society for medicine"},{"name":"Felix Neuberghs foundation, the Magnus Bergvall foundation"},{"name":"Swedish Society for Medicine"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.seizure.2018.11.013","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T12:11:00Z","timestamp":1542975060000},"page":"29-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Retention rate of first antiepileptic drug in poststroke epilepsy: A nationwide study"],"prefix":"10.1016","volume":"64","author":[{"given":"David","family":"Larsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8693-1014","authenticated-orcid":false,"given":"Signild","family":"\u00c5sberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kumlien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9445-4545","authenticated-orcid":false,"given":"Johan","family":"Zelano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2018.11.013_bib0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-1331.2004.00992.x","article-title":"The epidemiology of epilepsy in Europe - a systematic review","volume":"12","author":"Forsgren","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2018.11.013_bib0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/2396987316669000","article-title":"Association between poststroke epilepsy and death: a nationwide cohort study","volume":"1","author":"Zelano","year":"2016","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.seizure.2018.11.013_bib0015","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1212\/WNL.0000000000004009","article-title":"Poststroke epilepsy in long-term survivors of primary intracerebral hemorrhage","volume":"88","author":"Lahti","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.013_bib0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/STROKEAHA.111.000220","article-title":"Incidence and associations of poststroke epilepsy: the prospective South London Stroke Register","volume":"44","author":"Graham","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.seizure.2018.11.013_bib0025","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/epi.13448","article-title":"Epilepsy in cerebrovascular diseases: review of experimental and clinical data with meta-analysis of risk factors","volume":"57","author":"Ferlazzo","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.11.013_bib0030","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/1756285616654423","article-title":"Poststroke epilepsy: update and future directions","volume":"9","author":"Zelano","year":"2016","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.seizure.2018.11.013_bib0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000342669","article-title":"Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project)","volume":"34","author":"Consoli","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.seizure.2018.11.013_bib0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WNF.0b013e3180333069","article-title":"Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure","volume":"30","author":"Gilad","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.seizure.2018.11.013_bib0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.yebeh.2008.04.025","article-title":"Levetiracetam monotherapy for late poststroke seizures in the elderly","volume":"13","author":"Kutlu","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2018.11.013_bib0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.eplepsyres.2008.08.008","article-title":"Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study","volume":"82","author":"Belcastro","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2018.11.013_bib0055","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1212\/01.WNL.0000038388.57824.B6","article-title":"Gabapentin in late-onset poststroke seizures","volume":"59","author":"Alvarez-Sabin","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.013_bib0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2018.08.001","article-title":"Randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures: a systematic review with network meta-analysis","volume":"61","author":"Brigo","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2018.11.013_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1747-4949.2010.00557.x","article-title":"The Riks-Stroke story: building a sustainable national register for quality assessment of stroke care","volume":"6","author":"Asplund","year":"2011","journal-title":"Int J Stroke"},{"key":"10.1016\/j.seizure.2018.11.013_bib0070","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.seizure.2018.11.013_bib0075","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004094","article-title":"The incidence of SUDEP: a nationwide population-based cohort study","author":"Sveinsson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.013_bib0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.seizure.2015.06.016","article-title":"Choice of the first anti-epileptic drug in elderly patients with newly diagnosed epilepsy: a Finnish retrospective study","volume":"31","author":"Bruun","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2018.11.013_bib0085","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1007\/s00415-012-6509-3","article-title":"Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults","volume":"259","author":"Hamer","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2018.11.013_bib0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2018.09.026","article-title":"Treatment with antiepileptic drugs in patients with stroke. A change in clinical practice may be required","volume":"395","author":"Jabareen","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.seizure.2018.11.013_bib0095","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/01.WNL.0000167384.68207.3E","article-title":"New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine","volume":"64","author":"Rowan","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.013_bib0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-1211(99)00039-X","article-title":"Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group","volume":"37","author":"Brodie","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2018.11.013_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174659","article-title":"Cause of death in patients with poststroke epilepsy: results from a nationwide cohort study","volume":"12","author":"Hansen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.seizure.2018.11.013_bib0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.eplepsyres.2015.03.002","article-title":"Antiepileptic drug use for treatment of epilepsy and dyslipidemia: systematic review","volume":"113","author":"Vyas","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2018.11.013_bib0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/heartjnl-2014-305664","article-title":"Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications","volume":"101","author":"Bardai","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.seizure.2018.11.013_bib0120","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pds.2186","article-title":"Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study","volume":"20","author":"Olesen","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.seizure.2018.11.013_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1212\/WNL.0000000000003467","article-title":"AEDs after ICH: preventing the prophylaxis","volume":"88","author":"Koch","year":"2017","journal-title":"Neurology"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118306460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118306460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:51:08Z","timestamp":1761011468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131118306460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":25,"alternative-id":["S1059131118306460"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2018.11.013","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retention rate of first antiepileptic drug in poststroke epilepsy: A nationwide study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}